Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer research, Downregulation and upregulation, Ovarian cancer, Biology, Epigenetics, and PI3K/AKT/mTOR pathway.
NSD proteins in anti-tumor immunity and their therapeutic targeting by protein degraders
ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability
HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B
ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE
High glutamine suppresses osteogenesis through mTORC1-mediated inhibition of the mTORC2/AKT-473/RUNX2 axis
The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis
Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis
LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1
Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R
Identification of the Mutational Landscape of Gynecological Malignancies